AVE — Avecho Biotechnology Share News
0.000.00%
Last trade - 00:00- AU$55.10m
- AU$50.45m
- AU$1.24m
Australia's Avecho soars on signing licensing deal for recreational cannabis in U.S.
Brief: Avecho Biotechnology Enters Licensing, Supply Agreement With Team Saas Llc For Use Of Tpm In Recreational Products In Us
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 11:52:12
Australia Stock Exchange release from AVECHO BIOTECHNO : AVE license agreement for US recreational cannabis market
Australia Stock Exchange release from AVECHO BIOTECHNO : December 2021 Quarterly Activities Report & Appendix 4C
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:57:51
Australia Stock Exchange release from AVECHO BIOTECHNO : Application for quotation of securities - AVE
Australia Stock Exchange release from AVECHO BIOTECHNO : Section 708A Cleansing Statement
Brief: Avecho Biotechnology Enters Licensing And Supply Agreement With Medterra Pharma Llc
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 10:54:01
Australia Stock Exchange release from AVECHO BIOTECHNO : AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:10:20
Australia Stock Exchange release from AVECHO BIOTECHNO : Positive results from Avecho's Phase I trial of CBD soft-ge
Australia Stock Exchange release from AVECHO BIOTECHNO : September 2021 Quarterly Activities Report & Appendix 4C
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:00:54
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:00:20
Australia Stock Exchange release from AVECHO BIOTECHNO : Topical CBD pain study with Lambert Initiative approved
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:33:41
Australia Stock Exchange release from AVECHO BIOTECHNO : Dosing begins in Phase I PK trial testing CBD soft-gel